BioOutsource expands in Scotland; EU carries on with ban of GVK-tied drugs;

> BioOutsource, recently acquired by Sartorius Stedim Biotech, has opened a new facility in its native Scotland to support the development of biosimilars, planning to add 50 jobs in the process. More

> European regulators are standing by their decision to suspend the marketing of more than 700 drugs tied to a data scandal at GVK BioSciences, planning to institute a ban starting Aug. 21. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.